#1761 ·
This also applies to psoriasis, as it falls under the same umbrella of autoimmune diseases.
The FDA has approved the biologic drug Humira for treating Crohn's disease, and representatives from Abbott announced today that it should soon be added to the Medicare formulary.
Approval follows the drug receiving clearance for this indication back in February in the US, and more recently in June within the European Union.
Crohn's disease is a chronic inflammatory bowel disease that affects people of all ages, though it primarily impacts younger individuals, typically those under forty. While various treatment options exist, the disease still cannot be fully cured through medication or surgical means...
Humira was approved for Crohn's disease based on several studies demonstrating its effectiveness. A major benefit for patients is the ability to self-administer the treatment at home rather than requiring hospital visits, and it has shown positive immunological responses.
Up until now, Humira has been approved in the US for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The price per box is $2.50.
The FDA has approved the biologic drug Humira for treating Crohn's disease, and representatives from Abbott announced today that it should soon be added to the Medicare formulary.
Approval follows the drug receiving clearance for this indication back in February in the US, and more recently in June within the European Union.
Crohn's disease is a chronic inflammatory bowel disease that affects people of all ages, though it primarily impacts younger individuals, typically those under forty. While various treatment options exist, the disease still cannot be fully cured through medication or surgical means...
Humira was approved for Crohn's disease based on several studies demonstrating its effectiveness. A major benefit for patients is the ability to self-administer the treatment at home rather than requiring hospital visits, and it has shown positive immunological responses.
Up until now, Humira has been approved in the US for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The price per box is $2.50.